NRX Pharmaceuticals, Inc. SC 13D and SC 13D/A reports

Location
1201 Orange Street, Suite 600, Wilmington, DE
State of incorporation
Delaware
Fiscal year end
December 31
Data updated at
9/6/2024, 01:26 AM
Form type Sec Links Description Filing date Reporting date
SC 13D Report Sep 13, 2022
SC 13D/A Report Jun 17, 2022
SC 13D Report Jun 3, 2022
SC 13D/A Report AMENDMENT NO. 1 Nov 2, 2021
SC 13D/A Report SC 13D/A Jun 4, 2021
SC 13D Report SCHEDULE 13D Jun 3, 2021
SC 13D/A Report SC 13D/A May 26, 2021
SC 13D Report SCHEDULE 13D Nov 26, 2018
SC 13D/A Report FORM SC 13D/A Nov 21, 2018
SC 13D Report FORM SC 13D Dec 22, 2017